Ozempic (semaglutide) and Trulicity (dulaglutide) are brand-name subcutaneous injections. They’re both prescribed for adults with type 2 diabetes who may or may not have certain cardiovascular ...

The Trulicity pen -- an injectable drug for patients to manage their type 2 diabetes -- has been around for quite some time.

New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...

Doctors may prescribe drugs, including Trulicity, to help manage a person’s diabetes, but only certain parts of Medicare cover Trulicity costs. Trulicity is the brand-name medication for ...

Unsurprisingly, these stock pickers are capitalizing on an opportunity that's only recently become addressable.

Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading pharmaceutical company that sells Trulicity, Verzenio ...

The manufacturer of Mounjaro, Trulicity and other treatments for weight loss or diabetes accuses the U.S. Department of Health and Human Services of banning Big Pharma from implementing a cash ...

Some GLP-1s, like Ozempic (semaglutide), tirzepatide (Mounjaro), and dulaglutide (Trulicity), are usually taken weekly. Others, like liraglutide (Saxenda, Victoza), are typically administered daily.

However, Eli Lilly continued to develop GLP-1 drugs, getting Trulicity, which is used to treat type 2 diabetes, approved in 2014. By 2018, Trulicity would become Eli Lilly's top-selling drug ...

Investors familiar with the pharmaceutical giant already know this is the name behind the blockbuster diabetes treatment Trulicity, which produced more than $7 billion worth of sales last fiscal year.